19-15053631-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP6_Moderate
The NM_012114.3(CASP14):c.177G>A(p.Glu59Glu) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.00152 in 1,614,150 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 1 hom. )
Consequence
CASP14
NM_012114.3 splice_region, synonymous
NM_012114.3 splice_region, synonymous
Scores
2
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 4.94
Genes affected
CASP14 (HGNC:1502): (caspase 14) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This caspase has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
BP6
Variant 19-15053631-G-A is Benign according to our data. Variant chr19-15053631-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 713661.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP14 | NM_012114.3 | c.177G>A | p.Glu59Glu | splice_region_variant, synonymous_variant | Exon 3 of 7 | ENST00000427043.4 | NP_036246.1 | |
CASP14 | XM_011527861.2 | c.177G>A | p.Glu59Glu | splice_region_variant, synonymous_variant | Exon 3 of 6 | XP_011526163.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00123 AC: 187AN: 152150Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
187
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000955 AC: 240AN: 251260 AF XY: 0.000876 show subpopulations
GnomAD2 exomes
AF:
AC:
240
AN:
251260
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00156 AC: 2274AN: 1461882Hom.: 1 Cov.: 32 AF XY: 0.00150 AC XY: 1093AN XY: 727242 show subpopulations
GnomAD4 exome
AF:
AC:
2274
AN:
1461882
Hom.:
Cov.:
32
AF XY:
AC XY:
1093
AN XY:
727242
Gnomad4 AFR exome
AF:
AC:
9
AN:
33480
Gnomad4 AMR exome
AF:
AC:
11
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
22
AN:
26136
Gnomad4 EAS exome
AF:
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
AC:
0
AN:
86252
Gnomad4 FIN exome
AF:
AC:
5
AN:
53420
Gnomad4 NFE exome
AF:
AC:
2172
AN:
1112006
Gnomad4 Remaining exome
AF:
AC:
55
AN:
60396
Heterozygous variant carriers
0
137
274
412
549
686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00123 AC: 187AN: 152268Hom.: 1 Cov.: 32 AF XY: 0.00107 AC XY: 80AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
187
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
80
AN XY:
74450
Gnomad4 AFR
AF:
AC:
0.000481162
AN:
0.000481162
Gnomad4 AMR
AF:
AC:
0.000130839
AN:
0.000130839
Gnomad4 ASJ
AF:
AC:
0.000864553
AN:
0.000864553
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.00236702
AN:
0.00236702
Gnomad4 OTH
AF:
AC:
0.000473485
AN:
0.000473485
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Apr 10, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=20/80
disease causing
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 8
DS_DL_spliceai
Position offset: 0
Find out detailed SpliceAI scores and Pangolin per-transcript scores at